DEVELOPMENT OF NANOSTRUCTURED LIPID CARRIER FORMULATION CONTAINING OF RETINYL PALMITATE

Abstract

Objective: The purpose of this research is to develop a Nanostructure Lipid Carrier (NLC) formulation containing of Retinyl Palmitate.Methods: Preparation of NLC was carried out by ultrasonication method. The formulas of NLC were developed by using virgin coconut oil and oleic acid as a liquid lipids, cetyl palmitate, and stearic acid as solid lipids, Tween 80 and Poloxamer as a surfactant and glycerine as co-surfactant. Characterization of NLC consisted of visual appearance, morphology, particle size, polydispersity index (PI), and physical stability test using freeze-thaw, centrifugation, and accelerate stability test method.Results: Obtained NLC revealed a good characterization with the formulation of 7.2% of cetyl palmitate, 4.8% of oleic acid, 10% of Tween 80, 10% of glycerin, and 2% of retinyl palmitate. This NLC has a pale yellow appearance, globule size of 258±15.85 nm; and a polydispersity index of 0.31±0.09. It was also physically stable after centrifuged at 13,000 rpm for 30 min, during 4 cycles of freeze-thaw and storage at room temperature for 28 d. During storage for 28 d, retinyl palmitate in NLC had been degraded only about 15% in comparison with macroemulsion destroyed almost 50% of retinyl palmitate in the same time.Conclusion: NLC formulations with 7.2% cetyl palmitate, 4.8% of oleic acid, 10% of Tween 80, 10% of glycerol, and 2% of retinyl palmitate is the most optimal formula that showed a good characteristic. Stability study revealed that NLC provided better stability than macroemulsion.Keywords: Retinyl palmitate, NLC, Ultrasonication Methode 

Authors and Affiliations

Jessie Sofia Pamudji, Rachmat Mauludin, Nasya Indriani

Keywords

Related Articles

CYTOTOXICITY AND ANTIMICROBIAL ACTIVITY OF MONO-, DI- AND TRINUCLEAR RUTHENIUM(II) POLYPYRIDINE COMPLEXES

Objectives: To evaluate the in vitro cytotoxicity, antibacterial and antifungal activity of the synthesized mono-, di- and trinuclear ruthenium(II) polypyridine complexes.Methods: A series of synthesized ruthenium(II) co...

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF PHENYLEPHRINE HYDROCHLORIDE AND EBASTINE IN TABLET DOSAGE FORM

Objective: A new simple, accurate, precise, robust, reproducible and economic RP-HPLC method was developed for Phenylephrine Hydrochloride and Ebastine in marketed tablet dosage form.Methods: The Chromatographic separati...

ENHANCEMENT OF DISSOLUTION RATE OF HYDROCHLOROTHIAZIDE

Objective: The aim of this study was to enhance the dissolution rate of hydrochlorothiazide (HCTZ).Methods: Binary solid dispersions (SDs) of HCTZ with increasing weight ratios of poloxamer 407, polyethylene glycol 6000...

CARBAMAZEPINE INDUCED SLE-A RARE AND SERIOUS ADR

Carbamazepine is a commonly used antiseizure medication. Carbamazepine-induced SLE (Systemic Lupus Erythematosus) is a very rare phenomenon. Drug-induced SLE is an autoimmune disease caused by long-term use of certain dr...

IMPACT OF PHARMACIST INTERVENTION ON MEDICATION KNOWLEDGE AND ADHERENCE IN HEMODIALYSIS PATIENTS

Objective: The objectives of the study are to evaluate the medication knowledge and medication adherence in patients undergoing haemodialysis and to educate the patients regarding the importance of medication adherence t...

Download PDF file
  • EP ID EP577881
  • DOI -
  • Views 53
  • Downloads 0

How To Cite

Jessie Sofia Pamudji, Rachmat Mauludin, Nasya Indriani (2016). DEVELOPMENT OF NANOSTRUCTURED LIPID CARRIER FORMULATION CONTAINING OF RETINYL PALMITATE. International Journal of Pharmacy and Pharmaceutical Sciences, 8(2), 256-260. https://europub.co.uk/articles/-A-577881